Dr Ruth Akiyo Mizoguchi

Dr Ruth Akiyo Mizoguchi is a Care of the Elderly Consultant and Dementia Lead at the Chelsea and Westminster Hospital (CWH) NHS Foundation Trust and holds a post as an Honorary Senior Clinical Lecturer at Imperial College.

Ruth qualified from Tokai University School of Medicine, Japan and Imperial College, UK.  She has a special interest in dementia and has gone through training at the University of California San Francisco Memory Aging Centre, USA. During her specialist training she undertook dementia research at Imperial College, completed a year of overseas training at Queen Elizabeth Hospital, Hong Kong where she developed interested in Dementia.

At her current trust, she works closely with neurologists and together they have established a multi-disciplinary team (MDT) memory clinic with the opportunity for dementia research and have access to Clinical Trials at Imperial College. She also runs the Spina Bifida & Hydrocephalus MDT Clinic, which is the only adult clinic in the UK. With experience in Frailty Unit and neuro-rehabilitation, Ruth continues to lead various dementia research and quality improvement projects.

Prior to her current appointment she was a Care of the Elderly consultant & Dementia Lead at the Royal Free Hospital NHS Foundation Trust from 2012-2018 where she also set up a memory clinic.

Language : English, Japanese, Cantonese

Areas of Expertise: Cognitive Impairment / Dementia / General & Elderly Care Medicine

Professional Memberships: Royal College of Physicians, British Medical Association, British Geriatric Society

Publications:

PARO as a Biofeedback Medical Device for Mental Health in the COVID-19 Era. Shibata T, Hung L, Petersen S, Darling K, Inoue K, Martyn K, Hori Y, Lane G,Park D, Mizoguchi R, et al Sustainability, October 2021

Essentials: Ward-Based Management of Behavioural and Psychological Symptoms of Dementia. Nguyen J, Ko I, Martinez-Sosa, Mizoguchi R Student British Medical Journal, July 2021

Cerebral amyloid Angiopathy versus Alzheimer’ dementia : Diagnostic Conundrum.  Arberry J, Singh S, Mizoguchi R Artificial Intelligence and Medical Imaging , July 2020

Herpes Zoster Cerebral Vasculopathy in a Case of Cognitive Decline.  Dennis LM, Badger K, Mizoguchi R Biomedical Journal of Scientific & Technical Research, July 2019

Tau aggregation correlates with amyloid deposition in both mild cognitive impairment and Alzheimer’s disease subjects.  Dani M, Wood M, Mizoguchi R, et al. Journal of Alzheimer’ Disease, May 2019

Atypical presentation of Frontal Temporal Lobe Dementia. Haskin W, Wood J, Ting M, Anderson C, Bovill I, Carswell C, Mizoguchi R. QIMS, May 2019

Assessment of pharmacological approach in behavioural and psychological symptom of dementia with or without specialist input. Singh S, Abas T, Quin P, Reshat S, Wilson S, Thie A, Mizoguchi R. Age and Ageing 48(Supplement_1):i1-i15, Feb 2019

The delirium & population health informatics cohort study protocol: ascertaining the determinants and outcomes from delirium in a whole population. Davis D, Richardson S, Hornby J, Bowden H, Hoffman K, Weston-Clarke M, Green F, Chaturvedi N, Hughes AD, Kuhn D, Sampson E, Mizoguchi R, et al.  BMC Geriatric, Dec 2018 

Microglial activation correlates in vivo with both tau and amyloid in Alzheimer’s disease.  Dani M, Wood M, Mizoguchi R, et al.  Brain, June 2018

Posterior Cortical Atrophy: the value of quantitative imaging in the medicine and surgery. Ioannidis S, Roseman H, Duckett D, Mizoguchi R. QIMS, Sept 2017